Efficacy and safety of donepezil, galantamine, and rivastigmine for the treatment of Alzheimer’s disease: A systematic review and meta-analysis

QR Code

Efficacy and safety of donepezil, galantamine, and rivastigmine for the treatment of Alzheimer’s disease: A systematic review and meta-analysis

Richard A Hansen1, Gerald Gartlehner2, Aaron P Webb1, Laura C Morgan3, Charity G Moore4, Daniel E Jonas31School of Pharmacy, 3Cecil G Sheps Center for Health Services Research, University of North Carolina, Chapel Hill, NC, USA; 2Department for Evidence-based Medicine and Clinical Epidemiology, Danu...

Description complète

Enregistré dans:

Détails bibliographiques
Auteurs principaux:	Richard A Hansen, Gerald Gartlehner, Aaron P Webb, Laura C Morgan, Charity G Moore, Daniel E Jonas
Format:	article
Langue:	EN
Publié:	Dove Medical Press 2008
Sujets:	Geriatrics RC952-954.6
Accès en ligne:	https://doaj.org/article/d5c15d92899e49d28e97a25f7619b761
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

Clinical efficacy and safety of donepezil in the treatment of Alzheimer’s disease in Chinese patients
par: Zhang N, et autres
Publié: (2018)

Galantamine versus donepezil in Chinese patients with Alzheimer&rsquo;s disease: results from a randomized, double-blind study
par: Zhang Z, et autres
Publié: (2012)

Clinically meaningful treatment responses after switching to galantamine and with addition of memantine in patients with Alzheimer&rsquo;s disease receiving donepezil
par: Kano O, et autres
Publié: (2013)

Galantamine-ER for the treatment of mild-to-moderate Alzheimer’s disease
par: Ben Seltzer
Publié: (2009)

Two cases of Alzheimer&#39;s disease showing deterioration of behavioral and psychological symptoms of dementia induced by switching from rivastigmine to donepezil
par: Kimura T, et autres
Publié: (2012)

Effectiveness and tolerability of transdermal rivastigmine in the treatment of Alzheimer&rsquo;s disease in daily practice
par: Seibert J, et autres
Publié: (2012)

Rivastigmine for the treatment of dementia associated with Parkinson&rsquo;s disease
par: Jennifer L Reingold, et autres
Publié: (2007)

Formulation optimization of galantamine hydrobromide loaded gel drug reservoirs in transdermal patch for Alzheimer’s disease
par: Woo FY, et autres
Publié: (2015)

Effects of galantamine in a 2-year, randomized, placebo-controlled study in Alzheimer’s disease [Corrigendum]
par: Hager K, et autres
Publié: (2014)

Use of Methylphenidate in Excessive Daytime Sleepiness in Alzheimer’s Patients Treated with Donepezil: Case Series
par: Bidzan L, et autres
Publié: (2020)

Rivastigmine in the treatment of Alzheimer's disease: an update
par: Maria Luisa Onor, et autres
Publié: (2007)

The Efficacy of Transdermal Rivastigmine in Mild to Moderate Alzheimer’s Disease with Concomitant Small Vessel Cerebrovascular Disease: Findings from an Open-Label Study
par: Yatawara C, et autres
Publié: (2021)

Differences in efficacy and safety of pharmaceutical treatments between men and women: an umbrella review.
par: Gerald Gartlehner, et autres
Publié: (2010)

Long-term effect of galantamine on cognitive function in patients with Alzheimer’s disease versus a simulated disease trajectory: an observational study in the clinical setting
par: Nakagawa R, et autres
Publié: (2017)

Influence of rs1080985 single nucleotide polymorphism of the CYP2D6 gene on response to treatment with donepezil in patients with Alzheimer’s disease
par: Klimkowicz-Mrowiec A, et autres
Publié: (2013)

Domperidone effective in preventing rivastigmine-related gastrointestinal disturbances in patients with Alzheimer's disease
par: Kano O, et autres
Publié: (2013)

Impact of Plasma Donepezil Concentration on Behavioral and Psychological Symptoms of Dementia in Patients with Alzheimer’s Disease
par: Yoshiyuki Kagawa, et autres
Publié: (2021)

Memantine: a review of studies into its safety and efficacy in treating Alzheimer’s disease and other dementias
par: Stuart J Thomas, et autres
Publié: (2009)

Potential therapeutic effect of nanobased formulation of rivastigmine on rat model of Alzheimer&#39;s disease
par: Ismail MF, et autres
Publié: (2013)

Galantamine treatment in Alzheimer&#39;s disease: response and long-term outcome in a routine clinical setting
par: Wallin &Aring;K, et autres
Publié: (2011)

Rivastigmine: the advantages of dual inhibition of acetylcholinesterase and butyrylcholinesterase and its role in subcortical vascular dementia and Parkinson’s disease dementia
par: Kandiah N, et autres
Publié: (2017)

Rivastigmine in Chinese patients with subcortical vascular dementia
par: Vincent Mok, et autres
Publié: (2007)

Donepezil for mild cognitive impairment in Parkinson’s disease
par: Kyoungwon Baik, et autres
Publié: (2021)

Neuroinflammation in Alzheimer’s disease
par: Zhang FJ, et autres
Publié: (2015)

The Potential Effect of Insulin on AChE and Its Interactions with Rivastigmine In Vitro
par: Tahereh Jamshidnejad-Tosaramandani, et autres
Publié: (2021)

Feasibility and efficacy of cognitive telerehabilitation in early Alzheimer’s disease: a pilot study
par: Jelcic N, et autres
Publié: (2014)

A randomized, 4-week double-blind placebo control study on the efficacy of donepezil augmentation of lithium for treatment of acute mania
par: Chen J, et autres
Publié: (2013)

Impact of cholinesterase inhibitors on behavioral and psychological symptoms of Alzheimer’s disease: A meta-analysis
par: Noll Campbell, et autres
Publié: (2008)

Safety and efficacy of pegylated liposomal doxorubicin in HIV-associated Kaposi&rsquo;s sarcoma
par: Francesca Cainelli, et autres
Publié: (2009)

Donepezil reverses buprenorphine-induced central respiratory depression in anesthetized rabbits
par: SAKURABA,SHIGEKI, et autres
Publié: (2009)

Antagonism of morphine-induced central respiratory depression by donepezil in the anesthetized rabbit
par: TSUJITA,MIKI, et autres
Publié: (2007)

Olfactory dysfunction in Alzheimer’s disease
par: Zou YM, et autres
Publié: (2016)

Targeting neuroinflammation in Alzheimer’s disease
par: Bronzuoli MR, et autres
Publié: (2016)

Response to Alzheimer’s research paper
par: Tait HM
Publié: (2013)

Role of berberine in Alzheimer’s disease
par: Cai Z, et autres
Publié: (2016)

Different durations of cognitive stimulation therapy for Alzheimer’s disease: a systematic review and meta-analysis
par: Chen J, et autres
Publié: (2019)

Identification of the optimal cognitive drugs among Alzheimer’s disease: a Bayesian meta-analytic review
par: Liang JH, et autres
Publié: (2018)

Alzheimer’s disease: pathogenesis, diagnostics, and therapeutics
par: Tiwari S, et autres
Publié: (2019)

Magnetic resonance spectroscopy in Alzheimer’s disease
par: Graff-Radford J, et autres
Publié: (2013)

Association of interleukin-33 gene polymorphisms with susceptibility to late onset Alzheimer’s disease: a meta-analysis
par: Zhong X, et autres
Publié: (2017)